Chronic Lymphocytic Leukemia
- 19 October 1995
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 333 (16), 1052-1057
- https://doi.org/10.1056/nejm199510193331606
Abstract
Chronic lymphocytic leukemia (CLL), the most frequent form of leukemia in Western countries, is characterized by the clonal proliferation and accumulation of neoplastic B lymphocytes in the blood, bone marrow, lymph nodes, and spleen. The median age of patients at diagnosis is 65 years, with only 10 to 15 percent under 50 years of age. In most series, more men than women are affected. The course of the disease is variable. Whereas some patients with CLL have a normal life span, others die within five years after diagnosis. During the past few years, important advances have been made in the . . .Keywords
This publication has 44 references indexed in Scilit:
- The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoireImmunology Today, 1994
- Infections in Chronic Lymphocytic Leukemia: Risk Factors, and Impact on Survival, and TreatmentLeukemia & Lymphoma, 1994
- MDR1 Gene Expression in Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1994
- Mechanism of autoimmune hemolytic anemia in chronic lymphocytic leukemiaAmerican Journal of Hematology, 1993
- Alpha interferon in chronic lymphocytic leukaemiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Correction of neutropenia associated with chronic lymphocytic leukaemia following treatment with granulocyte-macrophage colony-stimulating factorAnnals of Hematology, 1991
- Treatment of Chronic Lymphocytic Leukemia: A Preliminary Report of Spanish (Pethema) TrialsLeukemia & Lymphoma, 1991
- Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of CancerJNCI Journal of the National Cancer Institute, 1990
- Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survivalBritish Journal of Haematology, 1989
- Intravenous Immunoglobulin for the Prevention of Infection in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 1988